PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease-Reference-Cited by-同舟云学术

PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease

Published:2018-01-29 Issue:1 Volume:15 Page:e1002497
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Srinivasan Priya,Wu Xiaofang,Basu Mousumi,Rossi Christopher,Sandler Anthony D.^ORCID

Funder

EVAN Foundation

Catherine Blair Foundation

Michael Sandler Cancer Reach Fund

Sheikh Zayed Institute of Pediatric Surgical Innovation

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference31 articles.

1. Mechanisms of neuroblastoma regression;GM Brodeur;Nat Rev Clin Oncol,2014

2. Neuroblastoma: molecular pathogenesis and therapy;CU Louis;Annu Rev Med,2015

3. Neuroblastoma;JM Maris;Lancet,2007

4. The blockade of immune checkpoints in cancer immunotherapy;DM Pardoll;Nat Rev Cancer,2012

5. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy;RH Schwartz;Cell,1992

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

2. Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma;Cancers;2024-08-17

3. Cancer Vaccines: Another Aspect to Immunotherapy;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-07-07

4. Near‐infrared photoimmunotherapy targeting PD‐L1: Improved efficacy by preconditioning the tumor microenvironment;Cancer Science;2024-04-26

5. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells;Molecules;2024-04-02